REPLIGEN CORP — Director's Dealing 2020

Jun 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2020-06-11

Reporting Person: EGLINTON MANNER CARRIE (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-11	Stock Option (Right to Buy)	$113.78	A	2794	Acquired	2030-06-11	Common Stock (2794)	Direct

Footnotes

F1: The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date.